0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

How Effective Are Treatments for Diabetic Retinopathy?

Frederick L. Ferris III, MD
JAMA. 1993;269(10):1290-1291. doi:10.1001/jama.1993.03500100088034.
Text Size: A A A
Published online

ANALYSIS of data from four decades of clinical research demonstrates that currently recommended treatments are considerably more effective in preventing blindness from proliferative diabetic retinopathy (PDR) than has been previously appreciated. In fact, careful follow-up, timely photocoagulation, and vitrectomy when necessary strikingly reduce the risk of blindness for patients with PDR. This remarkable finding lends even greater urgency to current efforts to ensure that virtually all persons with diabetes receive at least yearly dilated eye examinations and are offered appropriate treatment when indicated.

Based on the results of clinical trials supported by the National Eye Institute and extensive clinical experience, specific recommendations have been developed concerning for whom and when treatment is appropriate.1-5 Prior to the availability of these treatments, the development of PDR was reason for extreme concern by both patients and their physicians about the risk of impending blindness. A 1963 study by Beetham6 showed that

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();